PMC:7696151 / 88785-89087
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2673 | 68-71 | Chemical | denotes | DXC | MESH:D004318 |
| 2674 | 96-99 | Chemical | denotes | HCQ | MESH:D006886 |
| 2675 | 252-255 | Chemical | denotes | DXC | MESH:D004318 |
| 2676 | 268-277 | Chemical | denotes | ofloxacin | MESH:D015242 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T567 | 0-302 | Sentence | denotes | Furthermore, in a 1999 clinical study, the administration of 100 mg DXC twice daily plus 200 mg HCQ three times daily for at least 18 months led to a short duration of therapy and a reduction in recurrences compared to alternative treatments including DXC plus 200 mg ofloxacin three times daily [129]. |